Eiger BioPharmaceuticals, Inc. (EIGRQ)
OTCMKTS
· Delayed Price · Currency is USD
8.50
0.00 (0.00%)
Inactive · Last trade price
on Oct 1, 2024
Eiger BioPharmaceuticals Cash Flow Statement
Financials in millions USD. Fiscal year is January - December.
Millions USD. Fiscal year is Jan - Dec.
Fiscal Year | TTM | FY 2023 | FY 2022 | FY 2021 | FY 2020 | FY 2019 | 2018 - 2014 |
|---|---|---|---|---|---|---|---|
Period Ending | Dec '23 Dec 31, 2023 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 | Dec '20 Dec 31, 2020 | Dec '19 Dec 31, 2019 | 2018 - 2014 |
| Net Income | -74.96 | -74.96 | -96.78 | -33.92 | -65.05 | -70.25 | Upgrade
|
| Depreciation & Amortization | 0.75 | 0.75 | 0.84 | 0.8 | 0.65 | 0.49 | Upgrade
|
| Loss (Gain) From Sale of Investments | -1.11 | -1.11 | 0.68 | 1 | 0.12 | -0.47 | Upgrade
|
| Stock-Based Compensation | 5.01 | 5.01 | 8.32 | 7.9 | 5.97 | 5.68 | Upgrade
|
| Other Operating Activities | 1.5 | 1.5 | 3.44 | -45.78 | 1.02 | 0.95 | Upgrade
|
| Change in Accounts Receivable | 0.08 | 0.08 | 0.83 | -2.58 | - | - | Upgrade
|
| Change in Inventory | 1.63 | 1.63 | -1.37 | -2.42 | - | - | Upgrade
|
| Change in Accounts Payable | -6.84 | -6.84 | 1.15 | 3.23 | -1.9 | 0.58 | Upgrade
|
| Change in Other Net Operating Assets | -0.61 | -0.61 | -0.13 | 0.43 | -4 | -0.59 | Upgrade
|
| Operating Cash Flow | -74.55 | -74.55 | -83.01 | -71.34 | -63.19 | -63.61 | Upgrade
|
| Capital Expenditures | -0.23 | -0.23 | -0.34 | -0.23 | -0.26 | -0.48 | Upgrade
|
| Sale (Purchase) of Intangibles | - | - | - | 0.28 | - | - | Upgrade
|
| Investment in Securities | 74.46 | 74.46 | 9.97 | 14.98 | -44.53 | -16 | Upgrade
|
| Other Investing Activities | - | - | - | 46.49 | - | - | Upgrade
|
| Investing Cash Flow | 74.23 | 74.23 | 9.63 | 61.53 | -44.79 | -16.47 | Upgrade
|
| Long-Term Debt Issued | - | - | 39.84 | - | - | 6.63 | Upgrade
|
| Total Debt Issued | - | - | 39.84 | - | - | 6.63 | Upgrade
|
| Long-Term Debt Repaid | - | - | -33.28 | - | - | -1.67 | Upgrade
|
| Net Debt Issued (Repaid) | - | - | 6.56 | - | - | 4.96 | Upgrade
|
| Issuance of Common Stock | 0.06 | 0.06 | 71.79 | 3.66 | 97.49 | 54.17 | Upgrade
|
| Other Financing Activities | -0.02 | -0.02 | -1.4 | -0.49 | -0.02 | -0.93 | Upgrade
|
| Financing Cash Flow | 0.04 | 0.04 | 76.96 | 3.17 | 97.46 | 58.2 | Upgrade
|
| Foreign Exchange Rate Adjustments | -0.08 | -0.08 | - | - | - | - | Upgrade
|
| Net Cash Flow | -0.36 | -0.36 | 3.58 | -6.64 | -10.51 | -21.89 | Upgrade
|
| Free Cash Flow | -74.78 | -74.78 | -83.35 | -71.57 | -63.44 | -64.09 | Upgrade
|
| Free Cash Flow Margin | -474.11% | -474.11% | -618.14% | -589.42% | - | - | Upgrade
|
| Free Cash Flow Per Share | -50.66 | -50.66 | -60.07 | -63.25 | -67.63 | -84.38 | Upgrade
|
| Cash Interest Paid | 3.97 | 3.97 | 2.89 | 2.78 | 2.79 | 2.64 | Upgrade
|
| Cash Income Tax Paid | 0.27 | 0.27 | 0.06 | - | - | - | Upgrade
|
| Levered Free Cash Flow | -53.26 | -53.26 | -48.09 | -41.45 | -38.46 | -36.78 | Upgrade
|
| Unlevered Free Cash Flow | -49.84 | -49.84 | -45.51 | -39.22 | -36.21 | -34.66 | Upgrade
|
| Change in Net Working Capital | 10.5 | 10.5 | -3.62 | 0.11 | 3.95 | -2.49 | Upgrade
|
Source: S&P Capital IQ. Standard template. Financial Sources.